BVF Inc/il is 10% at LIGAND PHARMACEUTICALS INC (LGND). They have made 57 open-market trades across 27 companies since 2008, most recently 2025-10-09.
CIK 0001056807
39 open-market purchases totalling $86.2M since 2008, against 18 sales. Across 31 scored buys the stock is up 20.5% at ninety days, and 18.0 points ahead of the S&P over the same stretch.
32 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 19% | 28% | 48% |
| Avg Move | -10.7% | -1.2% | +20.5% |
| Alpha | -24.9% | -1.2% | +18.0% |
| Scored | 32 | 32 | 31 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 86% | 100% | 100% |
| Avg Move | -15.9% | -12.4% | -15.5% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EPIX | SELL | 2025-08-05 | 2025-08-07 | $1.88 | $293 | +0.5% | -87.5% | N/A |
| THRD | SELL | 2024-10-29 | 2024-10-31 | $14.30 | $20.9M | +8.5% | -10.4% | -62.5% |
| PNT | SELL | 2023-12-18 | 2023-12-20 | $12.45 | $427.3M | N/A | N/A | N/A |
| CGEM | BUY | 2022-05-12 | 2022-05-16 | $9.07 | $20.1M | -4.5% | +7.7% | +28.0% |
| KYMR | BUY | 2022-05-05 | 2022-05-09 | $19.44 | $8.3M | -25.0% | -15.8% | +58.3% |
| KYMR | BUY | 2022-01-27 | 2022-01-31 | $38.96 | $10.2M | -0.4% | -8.8% | -23.7% |
| RAIN | BUY | 2022-01-06 | 2022-01-10 | $12.00 | $6.7M | -25.1% | -37.3% | -64.8% |
| XOMA | SELL | 2021-03-31 | 2021-04-02 | $38.36 | $46.8M | -9.1% | -10.7% | -18.5% |
| INFI | SELL | 2021-02-11 | 2021-02-16 | $5.37 | $24.3M | -26.4% | -18.6% | -30.0% |
| GLYC | BUY | 2020-11-04 | 2020-11-06 | $2.60 | $5.0M | +30.0% | +22.6% | +29.7% |
| GLYC | BUY | 2020-10-30 | 2020-11-03 | $2.75 | $5.1M | +26.0% | +31.4% | +31.4% |
| FPRX | BUY | 2020-09-22 | 2020-09-24 | $3.80 | $122 | +20.1% | +30.9% | +354.5% |
| MRUS | BUY | 2020-09-10 | 2020-09-14 | $11.10 | $4.2M | +0.3% | +15.0% | +44.7% |
| FPRX | BUY | 2020-05-14 | 2020-05-18 | $4.10 | $2.2M | +17.8% | -2.9% | +8.4% |
| FPRX | BUY | 2019-10-23 | 2019-10-25 | $3.74 | $1.1M | +0.3% | -3.0% | +45.8% |
| XOMA | BUY | 2018-12-11 | 2018-12-13 | $14.44 | $877K | -13.9% | -5.0% | +3.7% |
| INFI | BUY | 2018-11-28 | 2018-11-30 | $1.30 | $130K | -13.7% | -15.1% | +12.9% |
| INFI | BUY | 2018-11-19 | 2018-11-21 | $1.37 | $4.0M | -12.9% | -27.3% | +2.2% |
| NVLS | BUY | 2017-05-09 | 2017-05-11 | $2.34 | $385K | -2.1% | -7.0% | N/A |
| INFI | BUY | 2016-12-16 | 2016-12-20 | $1.30 | $1.7M | -2.8% | +9.2% | +136.6% |
| CCXI | SELL | 2015-11-03 | 2015-11-05 | $7.00 | $2.5M | -48.7% | -9.1% | -54.1% |
| CCXI | SELL | 2015-06-09 | 2015-06-11 | $9.00 | $8.6M | -48.7% | -9.1% | -9.1% |
| ONTY | BUY | 2014-12-15 | 2014-12-17 | $1.82 | $688K | N/A | N/A | N/A |
| LGND | SELL | 2013-11-26 | 2013-11-29 | $57.27 | $30.2M | -9.9% | -3.4% | -3.4% |
| RIGL | SELL | 2013-11-19 | 2013-11-20 | $2.64 | $1.3M | -8.6% | -5.6% | -5.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| CGEM | 3,599,615 | $46.5M |
| RIGL | 646,559 | $29.7M |
| CCXI | 2,384,577 | $25.4M |
| FPRX | 541,116 | $20.6M |
| OLMA | 2,165,776 | $14.3M |
| THRD | 1,367,257 | $7.4M |
| NVLS | 643,908 | $6.2M |
| CRIS | 7,692,716 | $3.2M |
| EPIX | 6,194,224 | $1.2M |
| GLYC | 4,980,812 | $782K |
| ELDN | 232,068 | $494K |
| CAPS | 3,730,300 | $318K |
| INFI | 4,448,421 | $199K |
| RAIN | 185,388 | $115K |
| ONTY | 6,264,385 | — |
| FACT | 3,940,070 | — |
| SGXP | 3,378,574 | — |
| SUPG | 5,583,399 | — |
| CRXX | 8,459,999 | — |
| ADLR | 4,834,551 | — |
| AVGN | 8,085,515 | — |
| Total | $1.8B |
Shares reported on the most recent Form 4, priced at the 2025-08-07 close. 7 holdings could not be priced and are excluded from the total.
| Scored | 14 | 14 | 13 |